Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Simon Lovestone argues for the strength of the European Union for supporting dementia research.

Simon lovestone

Taken from 'The Lancet Psychiatry', published online 16 May, 2016.

'As professionals concerned for people with dementia today and dedicated to finding more effective treatment and prevention for dementia tomorrow, we value our membership of the European Union (EU) and are deeply concerned by the prospect of the UK exiting. The EU has made dementia research a priority and has made substantial funds available for research that is driving faster, more effective clinical trials that are our best hope of finding a disease-modifying therapy. With its strong science and translational research base, the UK is making a considerable contribution to these studies.'

Read the full article here.

Read more about Simon Lovestone's research group at the Department of Psychiatry, University of Oxford.